Search Results
Results found for "Affiong Ika Oqua"
Posts (97)
- 📰 GPCR Weekly News, May 6 to 12, 2024
Gutkind, and Francesco Raimondi for their work on The landscape of cancer-rewired GPCR signaling axes Affiong Ika Oqua, Dr.
- Breaking the Myth of High and Low Affinity Sites
In this session, you’ll gain: ✅ A framework for understanding when apparent multiple affinities really Every day spent misunderstanding the meaning of apparent affinity differences can slow your project’s The interpretation of high and low affinity binding sites on GPCRs. High and Low Affinity: What’s Really Going On? It’s common to observe two apparent affinities for a ligand under certain experimental conditions.
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
As 2025 comes to a close, this final edition of Weekly News focuses on how GPCR binding affinity experiments Terry’s Corner: GPCR Binding Affinity Experiments That Hold Up Orthosteric GPCR binding affinity experiments Yet small design choices—often treated as technical details—quietly reshape the affinity you think you estimates , leading to false confidence in Ki values derived from GPCR binding affinity experiments. Design GPCR binding affinity experiments that tell the truth , ensuring affinity data support—rather
Other Pages (18)
- This new study reveals how the conformation of parathyroid hormone (PTH) and the C-terminal helix α5 of Gα regulate the selective coupling of PTH1R to Gs or Gq. Through Cryo-EM and single-cell experiments, the authors show differences in binding affinity, duration, and strength. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️ https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function/allosteric-mechanism-in-the-distinctive-coupling-of-gq-and-gs-to-the-parathyroid-hormone-type-1-receptor #gpcr #drgpcr | Dr. GPCR Ecosystem
Through Cryo-EM and single-cell experiments, the authors show differences in binding affinity, duration Through Cryo-EM and single-cell experiments, the authors show differences in binding affinity, duration
- 10 GPCR pharmacology lessons. Zero fluff. Launching July 1, Terry’s Corner gives you the clarity and confidence to make better decisions—starting with: • The role of pharmacology in discovery strategy • Black & Leff’s operational model—finally made practical • Binding curves, orthosteric vs allosteric function, and real vs apparent affinity • Molecular dynamics and how they guide ligand design • Why Terry built this—and how it sharpens your next move 📅 Learn anytime. New course every week. 📬 Subscribe to The Kenakin Brief → https://www.terrykenakin.com #GPCRscience #drugdiscovery #TerrysCorner #GPCRpharmacology #ligandbinding | Dr. GPCR Ecosystem
model—finally made practical • Binding curves, orthosteric vs allosteric function, and real vs apparent affinity model—finally made practical 🟢 Binding curves, orthosteric vs allosteric function, and real vs apparent affinity
- Exploring the combination of molecular simulation, pharmacological assays, and NMR to reveal the molecular mechanism of biased activation at the vasopressin V2 receptor. Did you know that we work hard to bring you the most recent GPCR News, weekly? Catch up today in the Ecosystem using your free site membership! | Dr. GPCR Ecosystem
➡️ https://www.ecosystem.drgpcr.com/receptor-activation-and-signaling/high-affinity-elr%2B-chemokine-ligands-show-g-protein-bias-over


